Life Sciences & Healthcare Upcoming conferences
11-14 January - JPM Healthcare conference
14 January - Kempen & Co Biotech X-over Selection
The Kempen X-over Selection connects a curated list of private European Biotechs with global institutional investors active in the crossover space.
15 January – Kempen & Co IPO seminar
This two-way seminar will involve active interactions between our speakers (Onno van de Stolpe CEO Galapagos, Pierre Kemula CFO CureVac) & CEOs of top-notch private biotech companies planning to get on the US NASDAQ or a European Stock Exchange in the coming period and will be a unique opportunity to network and share experiences and ideas.
2-3 February - LSX World Congress
11 March - BioCapital Europe
13-14 April - Bio€quity Europe
15-16 April - Innovation for Health
21 April - 12 May - Kempen & Co Life Sciences Conference 2021
Kempen & Co Life Sciences Conference 2021: thematic virtual series
Our Life Sciences Conference is a central meeting place for global institutional investors and European Life Sciences companies. In 2021, our signature format - focused on one-on-one meetings, small group meetings and showcase sessions - will be divided into 4 thematic days:
21 April - Immuno and Targeted Oncology companies
28 April - Cell, Gene & RNA based companies
5 May - Autoimmune, Metabolic, & Infectious diseases companies
12 May - Specialty Pharma & Diagnostics companies
Like previous years, our conference will be attended by executives from a wide range of companies (selection below).
As one of the few focused merchant banks in Europe, Kempen is uniquely positioned as a specialist in the life sciences and healthcare markets. We provide European companies access to a global network of specialist and generalist investors. Our Life Sciences team has successfully executed over 140 transactions since its inception in 2005.